Embolization device constructed from expansile polymer
First Claim
Patent Images
1. An occlusion device consisting essentially of:
- an elongated, solid expansile element, that is flexible in an untreated state, consisting essentially of a poly(ethylene glycol) macromer and a pH sensitive monomer; and
a carrier element comprising a plurality of loops forming a helical shape disposed around the expansile elementwherein the elongated, solid, flexible expansile element is secured to the carrier element in a stretched configuration that is between about 125% and about 600% of its initial length.
2 Assignments
0 Petitions
Accused Products
Abstract
Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.
337 Citations
18 Claims
-
1. An occlusion device consisting essentially of:
-
an elongated, solid expansile element, that is flexible in an untreated state, consisting essentially of a poly(ethylene glycol) macromer and a pH sensitive monomer; and a carrier element comprising a plurality of loops forming a helical shape disposed around the expansile element wherein the elongated, solid, flexible expansile element is secured to the carrier element in a stretched configuration that is between about 125% and about 600% of its initial length. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A method of treating a lesion comprising:
-
providing an occlusion device consisting essentially of a carrier member, and an elongated, solid expansile element, that is flexible in an untreated state, consisting essentially of a poly(ethylene glycol) macromer and a pH sensitive monomer to the lesion wherein the elongated, solid expansile element is secured to the carrier member in a stretched configuration that is between about 125% and about 600% of its initial length and the carrier member is formed into a secondary configuration that is approximately the same diameter as the lesion. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16, 17, 18)
-
Specification